Paul Schimmel

Paul Schimmel

Fondateur chez
Reactive Biosciences, Inc.

Fortune : 1 M $ au 31/05/2026

85 ans
Health Technology
Commercial Services
Finance

Profil

Paul R.
Schimmel
was the founder of Reactive Biosciences, Inc. (founded 2021), Alkermes, Inc. (founded 1987), Metabolon, Inc. (founded 2000), Abide Therapeutics, Inc. (founded 2011; Director), aTyr Pharma, Inc. (founded 2005; Independent Director), Repligen Corp.
(founded 1981; Co-Chairman), Alnylam Pharmaceuticals, Inc. (founded 2002; Independent Director), Momenta Pharmaceuticals, Inc. (founded 2001; Director), and Sirtris Pharmaceuticals, Inc. (founded 2004; Director).
Dr. Schimmel is also the founder of Cubist Pharmaceuticals LLC..
Current positions include Director at KinDex Pharmaceuticals, Inc. and Tevard Biosciences, Inc., Professor at The Scripps Research Institute (since 1997) and Skaggs Institute For Chemical Biology, Member of the National Academy of Sciences, National Academy of Medicine (United States), National Academy of Inventors, American Academy of Arts & Sciences, American Philosophical Society, and National Academy of Medicine, Advisor at Longwood Fund Management LLC, and Venture Partner at CHP Management, Inc. Former positions include Chairman of the Biological Chemistry Division at the American Chemical Society, Director at Momenta, Inc., Independent Director at Tocagen, Inc. (2015–2020), Director at Avicena Group, Inc., Vividion Therapeutics, Inc., and Alkermes Plc, Professor at Massachusetts Institute of Technology, and Member of the Scientific Advisory Board at Illumina, Inc. Education includes a doctorate from Cornell University, a doctorate from Massachusetts Institute of Technology (1966), and undergraduate studies at Ohio Wesleyan University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/05/2026 2 201 056 ( 2,24 % ) 1 M $ 31/05/2026

Postes actifs de Paul Schimmel

SociétésPosteDébut
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Private Equity Investor -
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -
Fondateur 01/01/2021
Corporate Officer/Principal -
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Anciens postes connus de Paul Schimmel

SociétésPosteFin
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Paul Schimmel

Formation de Paul Schimmel

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

75

Relations au 1er degré

32

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées32

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Finance

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Distribution Services

National Academy of Medicine

Finance

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Skaggs Institute For Chemical Biology

  1. Bourse
  2. Insiders
  3. Paul Schimmel
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇